Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
5.39
+0.41 (8.23%)
Apr 28, 2025, 4:00 PM EDT - Market closed
AVR Revenue
In the year 2024, Anteris Technologies Global had annual revenue of $2.70M, down -1.17%. Anteris Technologies Global had revenue of $536.11K in the quarter ending December 31, 2024, a decrease of -1.51%.
Revenue (ttm)
$2.70M
Revenue Growth
-1.17%
P/S Ratio
68.29
Revenue / Employee
$19,875
Employees
136
Market Cap
184.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.70M | -32.00K | -1.17% |
| Dec 31, 2023 | 2.74M | -384.72K | -12.33% |
| Dec 31, 2022 | 3.12M | -2.55M | -44.93% |
| Dec 31, 2021 | 5.66M | 203.73K | 3.73% |
| Dec 31, 2020 | 5.46M | -6.54M | -54.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
AVR News
- 4 months ago - Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering - Business Wire
- 5 months ago - Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering - Business Wire
- 5 months ago - Cardiac device maker Anteris Technologies files for $75M IPO - Seeking Alpha
- 5 months ago - Australian medical device company Anteris Technologies Global files for a $75 million US IPO - Renaissance Capital
- 5 months ago - Anteris Technologies Global IPO Registration Document (S-1) - SEC.gov